Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
28.40B | 27.75B | 28.34B | 31.24B | 29.15B |
Gross Profit | ||||
12.03B | 9.79B | 8.77B | 9.40B | 9.30B |
EBIT | ||||
8.71B | 6.06B | 4.44B | 2.75B | 4.71B |
EBITDA | ||||
8.23B | 7.17B | 5.65B | 4.75B | 5.55B |
Net Income Common Stockholders | ||||
6.64B | 4.92B | 3.68B | 3.03B | 4.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
27.21B | 23.54B | 20.88B | 20.43B | 26.02B |
Total Assets | ||||
90.44B | 75.54B | 67.01B | 67.25B | 68.27B |
Total Debt | ||||
3.90B | 6.05B | 5.96B | 5.36B | 5.50B |
Net Debt | ||||
-9.27B | -7.52B | -3.59B | -1.23B | -5.63B |
Total Liabilities | ||||
20.72B | 18.33B | 17.88B | 16.20B | 15.54B |
Stockholders Equity | ||||
67.86B | 55.91B | 48.10B | 50.32B | 52.24B |
Cash Flow | Free Cash Flow | |||
10.28B | 6.17B | 6.43B | 2.48B | 4.38B |
Operating Cash Flow | ||||
10.28B | 7.34B | 7.48B | 5.24B | 4.88B |
Investing Cash Flow | ||||
-6.82B | -1.86B | -1.45B | -6.00B | -14.21B |
Financing Cash Flow | ||||
-3.83B | -1.54B | -3.42B | -3.71B | 5.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $20.99B | 21.10 | 10.75% | 1.09% | 0.63% | 34.09% | |
76 Outperform | $29.73B | 9.30 | 9.14% | ― | -2.60% | 16.71% | |
75 Outperform | $110.26B | 89.88 | 28.91% | ― | 18.36% | ― | |
61 Neutral | $1.89B | 6.70 | 8.74% | ― | -0.29% | -12.84% | |
58 Neutral | $26.42B | 2.90 | -10.89% | 4.33% | 2.18% | -46.94% | |
52 Neutral | $2.10B | ― | -2.96% | ― | -1.33% | -148.56% | |
49 Neutral | $208.49M | ― | -5.43% | ― | -24.10% | -953.50% |